ACM
AGN

Advent Capital Management’s Allergan plc AGN Stock Holding History

Advent Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,790
Closed -$428K – 332
2017
Q1 		$428K Buy
+1,790
New +$417K 0.01% 196

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advent Capital Management's AGN Position: Q2 2017 in Review

Advent Capital Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 1,790 shares — an estimated $428K sold.

Advent Capital Management first reported a position in AGN in Q1 2017 and held it in 1 quarter. The position peaked at $428K in Q1 2017. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Advent Capital Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Advent Capital Management sold 1,790 Allergan plc shares in Q2 2017, an estimated $428K.
  • Advent Capital Management first reported a position in Allergan plc in Q1 2017 and held it in 1 quarter.
  • Advent Capital Management's Allergan plc position peaked at $428K in Q1 2017.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Advent Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.